Total Payments
$6,340
2024 Payments
$5,254
Companies
20
Transactions
115
Medicare Patients
4,238
Medicare Billing
$547,548
Payment Breakdown by Category
Education$4,000 (63.1%)
Food & Beverage$1,750 (27.6%)
Travel$590.50 (9.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $4,000 | 2 | 63.1% |
| Food and Beverage | $1,750 | 110 | 27.6% |
| Travel and Lodging | $590.50 | 3 | 9.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| INTUITIVE SURGICAL, INC. | $4,639 | 7 | $0 (2024) |
| GlaxoSmithKline, LLC. | $551.62 | 48 | $0 (2024) |
| Pulmonx Corporation | $251.42 | 4 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $137.86 | 9 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $114.59 | 8 | $0 (2024) |
| Mylan Specialty L.P. | $111.45 | 7 | $0 (2024) |
| GENZYME CORPORATION | $107.77 | 6 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $87.45 | 6 | $0 (2022) |
| Olympus Corporation of the Americas | $55.89 | 2 | $0 (2018) |
| Amgen Inc. | $49.14 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,254 | 41 | INTUITIVE SURGICAL, INC. ($4,639) |
| 2023 | $376.60 | 26 | GlaxoSmithKline, LLC. ($150.92) |
| 2022 | $190.48 | 13 | GlaxoSmithKline, LLC. ($69.30) |
| 2021 | $110.33 | 7 | Bio Products Laboratory USA, Inc. ($22.04) |
| 2020 | $42.25 | 3 | Insmed, Inc. ($14.48) |
| 2019 | $266.11 | 20 | GlaxoSmithKline, LLC. ($114.26) |
| 2018 | $69.44 | 3 | Olympus Corporation of the Americas ($55.89) |
| 2017 | $31.27 | 2 | Amgen Inc. ($16.45) |
All Payment Transactions
115 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.57 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | Pulmonx Corporation | ZEPHYR ENDOBRONCHIAL VALVE (Device) | Food and Beverage | Cash or cash equivalent | $179.78 | General |
| Category: PULMONOLOGY | ||||||
| 11/06/2024 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $26.04 | General |
| Category: PULMONOLOGY | ||||||
| 11/04/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $28.78 | General |
| 10/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Immunology | ||||||
| 10/16/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $0.67 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: Respiratory | ||||||
| 09/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: RESPIRATORY | ||||||
| 09/19/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: RESPIRATORY | ||||||
| 09/18/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Respiratory | ||||||
| 08/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: RESPIRATORY | ||||||
| 08/06/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $31.80 | General |
| Category: SURGERY | ||||||
| 07/30/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Education | In-kind items and services | $1,500.00 | General |
| Category: SURGERY | ||||||
| 07/16/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 07/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/27/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $231.86 | General |
| Category: SURGERY | ||||||
| 06/26/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Education | In-kind items and services | $2,500.00 | General |
| Category: SURGERY | ||||||
| 06/26/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: SURGERY | ||||||
| 06/19/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/13/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Respiratory | ||||||
| 06/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: RESPIRATORY | ||||||
| 06/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: RESPIRATORY | ||||||
| 05/31/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $9.97 | General |
| Category: RESPIRATORY | ||||||
| 05/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $12.60 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,310 | 1,725 | $569,500 | $146,646 |
| 2022 | 16 | 1,168 | 1,513 | $528,631 | $134,266 |
| 2021 | 14 | 1,014 | 1,375 | $523,326 | $138,288 |
| 2020 | 12 | 746 | 1,098 | $541,670 | $128,347 |
Total Patients
4,238
Total Services
5,711
Medicare Billing
$547,548
Procedure Codes
58
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 133 | 248 | $180,048 | $44,744 | 24.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 145 | 217 | $74,431 | $22,127 | 29.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 187 | 265 | $63,600 | $17,771 | 27.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 118 | 177 | $64,251 | $17,492 | 27.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 165 | 229 | $56,563 | $15,796 | 27.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 44 | 44 | $32,252 | $6,226 | 19.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 69 | 69 | $25,116 | $5,957 | 23.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 33 | 33 | $14,817 | $3,653 | 24.7% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 30 | 35 | $12,740 | $3,208 | 25.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $12,673 | $3,006 | 23.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 15 | $7,509 | $2,349 | 31.3% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 21 | 21 | $11,874 | $1,362 | 11.5% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 105 | 112 | $5,190 | $1,129 | 21.7% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 106 | 113 | $3,667 | $861.42 | 23.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 72 | 75 | $3,397 | $641.89 | 18.9% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 46 | 49 | $1,372 | $325.24 | 23.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 168 | 272 | $197,472 | $49,419 | 25.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 212 | 304 | $72,960 | $18,497 | 25.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 176 | 237 | $58,539 | $17,877 | 30.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 122 | 172 | $58,996 | $14,695 | 24.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 59 | 84 | $30,492 | $8,792 | 28.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 48 | 48 | $35,050 | $7,645 | 21.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 43 | 44 | $19,756 | $5,098 | 25.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 52 | 52 | $18,928 | $4,595 | 24.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $7,714 | $1,970 | 25.5% |
About Dr. Christopher Decotiis, MD
Dr. Christopher Decotiis, MD is a Pulmonary Disease healthcare provider based in Summit, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/24/2008. The National Provider Identifier (NPI) number assigned to this provider is 1346401130.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Decotiis, MD has received a total of $6,340 in payments from pharmaceutical and medical device companies, with $5,254 received in 2024. These payments were reported across 115 transactions from 20 companies. The most common payment nature is "Education" ($4,000).
As a Medicare-enrolled provider, Decotiis has provided services to 4,238 Medicare beneficiaries, totaling 5,711 services with total Medicare billing of $547,548. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Summit, NJ
- Active Since 06/24/2008
- Last Updated 09/02/2016
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1346401130
Products in Payments
- Da Vinci Surgical System (Device) $4,639
- TRELEGY ELLIPTA (Drug) $322.57
- DUPIXENT (Biological) $222.36
- ZEPHYR ENDOBRONCHIAL VALVE (Device) $179.78
- NUCALA (Biological) $158.37
- CHARTIS CATHETER (Device) $71.64
- YUPELRI (Drug) $63.52
- FASENRA (Biological) $61.94
- TEZSPIRE (Biological) $61.64
- OFEV (Drug) $56.97
- Olympus Capital Accessories (Device) $55.89
- Yupelri (Drug) $47.93
- AREXVY (Drug) $42.89
- Arikayce (Drug) $39.43
- STIOLTO RESPIMAT (Drug) $30.48
- Xolair (Biological) $29.33
- Xhance (Drug) $28.99
- CUVITRU (Biological) $26.23
- Gammaplex (Drug) $22.04
- AIRSUPRA (Drug) $20.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Summit
Frederic Scoopo, Md, MD
Pulmonary Disease — Payments: $16,772
Pulmonary Disease $16,772
Federico Cerrone, M.d, M.D
Pulmonary Disease — Payments: $12,817
Pulmonary Disease $12,817
Erwin Oei, Md, MD
Pulmonary Disease — Payments: $4,118
Pulmonary Disease $4,118
Edward Dimitry, Md, MD
Pulmonary Disease — Payments: $1,192
Pulmonary Disease $1,192
Chirag Shah, Md, MD
Pulmonary Disease — Payments: $909.09
Pulmonary Disease $909.09
Andrew Toscano, M.d, M.D
Pulmonary Disease — Payments: $760.34
Pulmonary Disease $760.34